Prevalence of antimicrobial resistance in Enterococcus isolates in Australia, 2005: Report from the Australian Group on Antimicrobial Resistance
DOI:
https://doi.org/10.33321/cdi.2007.31.42Keywords:
antibiotic resistance, enterococcus, vancomycinAbstract
Antibiotic resistance in Enterococcus species causing clinical disease was examined in a point-prevalence study in 2005. Twenty-two sites around Australia collected up to 100 consecutive isolates and tested them for susceptibility to ampicillin, vancomycin, high-level gentamicin and/or high-level streptomycin using standardised methods. Results were compared to similar surveys conducted in 1995, 1999 and 2003. In the 2005 survey, Enterococcus faecalis (1,987 strains) and E. faecalis (180 strains) made up 98.6% of the 2,197 isolates tested. Ampicillin resistance was common (77%) in E. faecium, but rare still in E. faecalis (0.2%). Resistance to vancomycin was 7.2% in E. faecium and 0.2% in E. faecalis; the vanB gene was detected in all vancomycin-resistant isolates. High-level resistance to gentamicin was 35.8% in E. faecalis and 52.2% in E. faecium; the figures for high-level streptomycin resistance were 10.3% and 60.2% respectively. Compared to previous Australian Group on Antimicrobial Resistance surveys in 1995, 1999 and 2003, the proportions of vancomycin resistance and high-level gentamicin resistance in enterococci are increasing. It is important to have an understanding of the occurrence of vancomycin resistant enterococci and high level aminoglycoside resistance in Australia to guide infection control practices, antibiotic prescribing policies and drug regulatory decisions. Commun Dis Intell 2007;31:392–397.
Downloads
References
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–485.
Kamarulzaman A, Tosolini FA, Boquest AL, Geddes JE, Richards MJ. Vancomycin-resistant Enterococcus faecium in a liver transplant patient. Aust NZ J Med 1995;25:560.
Bell J, Turnidge J, Coombs G, O’Brien F. Emergence and epidemiology of vancomycin-resistant enterococci in Australia. Commun Dis Intell 1998;22:249–252.
Christiansen KJ, Tibbett PA, Beresford W, Pearman JW, Lee RC, Coombs GW, et al. Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect Control Hosp Epidemiol 2004;25:384–390.
Cooper E, Paull A, O’Reilly M. Characteristics of a large cluster of vancomycin-resistant enterococci in an Australian hospital. Infect Control Hosp Epidemiol 2002;23:151–153.
Bartley PB, Schooneveldt JM, Looke DF, Morton A, Johnson DW, Nimmo GR. The relationship of a clonal outbreak of Enterococcus faecium vanA to methicillin-resistant Staphylococcus aureus incidence in an Australian hospital. J Hosp Infect 2001;48:43–54.
MacIntyre CR, Empson M, Boardman C, Sindhusake D, Lokan J, Brown GV. Risk factors for colonization with vancomycin-resistant enterococci in a Melbourne hospital. Infect Control Hosp Epidemiol 2001;22:624–629.
Padiglione AA, Grabsch EA, Olden D, Hellard MI, Sinclair M, Fairley CK, et al. Fecal colonization with vancomycin-resistant enterococci in Australia. Emerg Infect Dis 2000;6:534–536.
Joels CS, Matthews BD, Sigmon LB, Hasan R, Lohr CE, Kercher KW, et al. Clinical characteristics and outcomes of surgical patients with vancomycin-resistant enterococcal infections. Am Surg 2003;69:514–519.
DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005;41:327–333.
DiazGranados CA, Jernigan JA. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis 2005;191:588–595.
Kazanjian P. Infective endocarditis: Review of 60 cases treated in community hospitals. Infect Dis Clin Pract 1993;5:41.
Serra P, Brandimarte C, Martino P, Carlone S, Giunchi G. Synergistic treatment of enterococcal endocarditis. Arch Intern Med 1977;137:1562–1567.
Megran D. Enterococcal endocarditis. [Review] Clin Infect Dis 1992;15:63–71.
Pelletier L, Petersdorf R. Infective endocarditis: a review of 125 cases from the University of Washington Hospitals, 1963–72. Medicine (Baltimore) 1977;56:287–313.
Murray B. The life and times of the Enterococcus. [Review] Clin Microbiol Rev 1990;3:46–65.
Eliopoulos GM, Eliopoulis CT. Therapy of enterococcal infections. [Review] Eur J Clin Microbiol Infect Dis 1990;9:118–126.
Bell S, Gatus B, Pham J, Rafferty D. Antibiotic susceptibility testing by the CDS method: A manual for medical and veterinary laboratories. Third edition 2004 Available from: www.med.unsw.edu.au/pathology-cds
BSAC disc diffusion method for antimicrobial testing. Version 3.1 2004. Available from: www.bsac.org.uk
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Sixteenth Informational Supplement. M100-S16. CLSI, Villanova, PA, USA. 2006.
Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. Seventh edition. M7-A7. CLSI, Villanova, PA, USA. 2006.
National Committee on Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests: approved standard. Eighth edition. M2-A8. NCCLS, Wayne, PA, USA. 2003.
McAlister T, George N, Faoagali J, Bell J. Isolation of a β-lactamase positive vancomycin resistant Enterococcus faecalis; first case in Australia. Commun Dis Intell 1999:23:237–239.
Bell J, Paton JC, Turnidge J. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of the isolates. J Clin Microbiol 1998;36:2187–2190.
Downloads
Published
How to Cite
License
Copyright (c) 2007 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
